Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: January 2007
-
By Mark Chael — On Thursday, January 11, 2007, Digene filed suit against Third Wave Technologies, Inc. in the U.S. District Court for the Western District of Wisconsin (Case No. 07-C-0022-C) alleging infringement of U.S. Patent No. 5,643,715 (the '715 patent), in the latest skirmish of the ongoing battle between these two companies…
-
By Jason Derry — Tanox Inc. has announced that its shareholders have approved Genentech's offer to acquire the company for $20 per share ($919 million). Tanox is a biotechnology company located in Houston, TX that focuses on discovery and development of biotherapeutics. Tanox's approved drug Xolair® (omalizumab) is the first anti-IgE antibody on…
-
By Jason Derry — Trellis Bioscience, Inc. has announced an agreement with PDL BioPharma, Inc. relating to discovering monoclonal antibodies that recognize a PDL antigen. Under the agreement, Trellis will utilize its CellSpot technology to screen for hybridomas that produce antibodies of interest. Once particular hybridomas are identified, PDL BioPharma will attempt to…
-
It may be too late to sign up for "Launching a Biotech or Medical Device Start-Up: What Does it Take to be Successful?" a sold-out entrepreneurial education event hosted by the Illinois Technology Enterprise Center-Evanston on January 17, 2007, in Chicago, Illinois. However, if you're in the Chicago Metro area on Saturday, January 20, 2007,…
-
By Jason Derry — Research and Markets recently announced the availability of two new reports relating to the biotechnology industry: "Biotechnology in the United States" and "Biopartnering Strategies: Maximizing Returns from Biotechnology Deal-making." According to the Research and Markets website, "Biotechnology in the United States" provides data and analysis relating to trends and…
-
January 29-30, 2007 – Biotechnology 2007 (Law Seminars International) – San Francisco, CA January 29-30, 2007 – BIO-Asia Partnering Conference (Biotechnology Industry Organization) – Tokyo, Japan February 27-28, 2007 – Patent Portfolio Management (American Conference Institute) – New York, NY April 16-18, 2007 – Biotechnology: Patent Prosecution, Licensing, Litigation & Hatch-Waxman (Patent Resources Group) –…
-
Permanent Injunction Issued Against Abbott HCV Genotyping Test Kit By Robert Dailey — District Judge Barbara Crabb of the Western District of Wisconsin has issued a permanent injunction against Abbott that halts worldwide sales of its HCV genotyping test kits. In an opinion issued last week (and reported on Patent Docs), the Court…
-
Patent Resources Group is providing a course entitled "Biotechnology: Patent Prosecution, Licensing, Litigation & Hatch-Waxman" in Orlando on April 16-18, 2007. According to the PRG website, the course will focus on: Biotechnology Patent Prosecution; Biotechnology Patent Enforcement; the Hatch-Waxman Effect on Biotechnology Patent Practice; and Licensing Biotechnology Inventions. A number of other courses are being…
-
By Jason Derry — CytRx Corp. has announced that it has contributed its RNA interference portfolio to RXi Pharmaceuticals Corp. CytRx owns 85% of RXi while the remaining 15% will be owned by RXi's scientific advisory board. The members of the advisory board, subject to consent from each member's employer, include Craig C.…
-
By Kevin Noonan — Back in the 1970's, Firesign Theater had a comedy album entitled "Everything You Know is Wrong." This seems to be the Supreme Court's current opinion on the Federal Circuit; the Court hasn't actually affirmed a CAFC decision since J.E.M. Ag Supply v. Pioneer Hi-Bred Int'l. Inc. in 2001. The…
Patent Docs 